Clinical Trial Update: ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated concomitant administration of ZOSTAVAX with PNEUMOVAX 23; the study is completed and results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Pneumococcal Infection

Drugs mentioned

• Pneumovax 23 (Pneumococcal polysaccharide vaccine 23-valent)
• Zostavax (Varicella zoster vaccine live)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster, Pneumococcal Infection | Phase 3 | Status: COMPLETED | Results posted: 2009-05-13